Patents Assigned to Bellerophon Pulse Technologies LLC
  • Pulsed Administration Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension
    Publication number: 20200384014
    Abstract: Described herein are methods of treating pulmonary hypertension by maintaining dosing frequency and/or minimizing skipped breaths during pulsed administration of inhaled nitric oxide.
    Type: Application
    Filed: December 28, 2018
    Publication date: December 10, 2020
    Applicant: Bellerophon Pulse Technologies LLC
    Inventors: Deborah QUINN, Parag SHAH, Martin DEKKER
  • Use Of Inhaled Nitric Oxide And Oxygen For The Treatment Of Pulmonary Hypertension
    Publication number: 20200360425
    Abstract: Described herein are methods of using inhaled nitric oxide for treating pulmonary hypertension, improving exercise capacity and/or reducing oxygen desaturation in a patient.
    Type: Application
    Filed: December 28, 2018
    Publication date: November 19, 2020
    Applicant: Bellerophon Pulse Technologies LLC
    Inventors: Deborah Quinn, Parag Shah
  • Use Of Inhaled Nitric Oxide For The Improvement Of Right And/Or Left Ventricular Function
    Publication number: 20200360647
    Abstract: Described herein are methods of using inhaled nitric oxide for improving and/or maintaining right ventricular function and/or left ventricular function. Some methods relate to the long-term administration of inhaled nitric oxide to a patient with pulmonary hypertension.
    Type: Application
    Filed: August 29, 2018
    Publication date: November 19, 2020
    Applicant: Bellerophon Pulse Technologies LLC
    Inventors: Deborah Quinn, Parag Shah
  • Use Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension Associated With Lung Disease
    Publication number: 20200188319
    Abstract: Described herein are methods of using inhaled nitric oxide for treating pulmonary hypertension and/or improving oxygen saturation in a patient with a ventilation-perfusion (V/Q) mismatch and/or pulmonary hypertension associated with lung disease.
    Type: Application
    Filed: August 29, 2018
    Publication date: June 18, 2020
    Applicant: Bellerophon Pulse Technologies LLC
    Inventors: Deborah Quinn, Parag Shah